✦ LIBER ✦

O-108 Gefitinib as a first-line therapy of advanced or metastaticadenocarcinoma of the lung in never-smokers

✍ Scribed by Lee, D.; Han, J.; Lee, E.; Kim, H.; Kim, H.; Hong, E.; Lee, J.

Book ID: 118572656
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 148 KB
Volume: 49
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(05)80242-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Early neutrophil-to-lymphocyte ratio red

Early neutrophil-to-lymphocyte ratio reduction as a surrogate marker of prognosis in never smokers with advanced lung adenocarcinoma receiving gefitinib or standard chemotherapy as first-line therapy

✍ Youngjoo Lee, Sun Hye Kim, Ji-Youn Han, Heung Tae Kim, Tak Yun, Jin Soo Lee 📂 Article 📅 2012 🏛 Springer-Verlag 🌐 English ⚖ 354 KB

9139 Lapatinib as maintainence treatment

9139 Lapatinib as maintainence treatment after first line treatment of metastatic adenocarcinomas of lung in never smokers or seldom smokers

✍ Pandey, R.; Dey, S.; Bose, C.; Mukhopadhyay, A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 66 KB

131PD LAPATINIB WITH CHEMOTHERAPY IN FIR

131PD LAPATINIB WITH CHEMOTHERAPY IN FIRST-LINE TREATMENT OF ADVANCED NSCLC IN NEVER SMOKERS OR SELDOM SMOKERS

✍ Pandey, R.; Dey, S.; Mukhopadhyay, A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Gefitinib vs. chemotherapy as first-line

Gefitinib vs. chemotherapy as first-line therapy in advanced non-small cell lung cancer: Meta-analysis of phase III trials

✍ Ku, Geoffrey Y.; Haaland, Benjamin A.; de Lima Lopes, Gilberto 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 281 KB

Randomized phase II trial of first-line

Randomized phase II trial of first-line treatment with pemetrexed-cisplatin, followed sequentially by gefitinib or pemetrexed, in East Asian, never-smoker patients with advanced non-small cell lung cancer

✍ Ahn, Myung-Ju; Yang, James Chih-Hsin; Liang, Jun; Kang, Jin-Hyoung; Xiu, Qingyu; 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 550 KB

A phase II trial of gefitinib as mainten

A phase II trial of gefitinib as maintenance therapy after first-line chemotherapy for advanced non-small cell lung cancer in China

✍ Lu Yang; Zhi-jie Wang; Tong-tong An; Hua Bai; Jun Zhao; Jian-chun Duan; Ping-pin 📂 Article 📅 2010 🏛 Chinese Anti-Cancer Association 🌐 English ⚖ 283 KB